Clinical trial on the effects of thalidomide on hemoglobin synthesis in patients with moderate thalassemia intermedia

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)

Ersi Voskaridou, Dimitrios Christoulas, Antonios Bilalis et al. · Blood · 2009 · 432 citations · Full text

Medicine, Hematology, Pharmacotherapy +5

Thalidomide induces γ-globin gene expression through increased reactive oxygen species–mediated p38 MAPK signaling and histone H4 acetylation in adult erythropoiesis

Wulin Aerbajinai, Jianqiong Zhu, Zhigang Gao et al. · Blood · 2007 · 141 citations · Full text

Life Sciences, Genetics, Molecular Biology +11

Beta O-thalassemia intermedia

Gabriel Cividalli, H Kerem, E. Ezeckiel et al. · Blood · 1978 · 137 citations · Full text

Medicine, Biochemistry, Hematology +12

Hydroxyurea in thalassemia intermedia—a promising therapy

Ashish Dixit, T. Chatterjee, Pravas Mishra et al. · Annals of Hematology · 2005 · 108 citations

Medicine, Hematology, Pharmacotherapy +6

A pilot study of subcutaneous decitabine in β-thalassemia intermedia

Nancy F. Olivieri, Yogen Saunthararajah, Vivek Thayalasuthan et al. · Blood · 2011 · 87 citations · Full text

Medicine, Hematology, Pharmacology +6